A5056237707- Diabetes Treatment and Management
- Health Systems, Economic Evaluations, Quality of Life
- Medication Adherence and Compliance
- Prostate Cancer Treatment and Research
- Fatty Acid Research and Health
- Statistical Methods in Clinical Trials
- Rheumatoid Arthritis Research and Therapies
- Diabetes Management and Education
- Metabolism, Diabetes, and Cancer
- Neurological Disease Mechanisms and Treatments
- Health and Wellbeing Research
- Patient-Provider Communication in Healthcare
- Heart Failure Treatment and Management
- Patient Satisfaction in Healthcare
- PARP inhibition in cancer therapy
- Lymphoma Diagnosis and Treatment
- Radiopharmaceutical Chemistry and Applications
- Hepatitis C virus research
- Diet and metabolism studies
- Dental Health and Care Utilization
- Diabetes Management and Research
- Colorectal Cancer Treatments and Studies
- Management of metastatic bone disease
- Cancer Treatment and Pharmacology
- Pharmacology and Obesity Treatment
University of Benghazi
2024
Janssen (United States)
2014-2020
Janssen (Belgium)
2013-2014
University of California, Los Angeles
2006-2007
Abstract Objective To evaluate the American College of Rheumatology (ACR) starter set quality measures for rheumatoid arthritis (RA) in an actual patient cohort that preceded publication measures. Methods We retrospectively applied 2006 ACR criteria to a prospectively studied 568 patients with RA treated by 1,932 unique physicians including 255 different rheumatologists between years 1999 and 2003. Data on performance were obtained from self‐report surveys medical record review within 12...
The study aimed to adapt the original English-language oral health values scale (OHVS) Arabic culture and test its psychometric properties.
Abstract Objective To construct quality measures with measurement validity and meaning for clinicians. Methods We conducted a prospective cohort study of rates change in disease‐modifying antirheumatic drug (DMARD) and/or systemic corticosteroid or dose 568 patients rheumatoid arthritis (RA) across 6,159 clinical encounters within 12 months to examine how changes specifications adherence. Results Rates DMARD were sensitive regarding the intensity disease activity (severe moderate), duration...